NCT00541125View on ClinicalTrials.gov

G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

bevacizumab

BIOLOGICAL

filgrastim

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT00541125 - G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter